Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients

Estrid V S Høgdall, Claus K Høgdall, Lise Christensen, Eva Glud, Jan Blaakaer, Johannes E Bock, Jens Vuust, Bent Nørgaard-Pedersen, Susanne K Kjaer

31 Citationer (Scopus)

Abstract

BACKGROUND: The p53 gene is frequently mutated in various human tumours. In addition, single nucleotide polymorphisms are often observed in exons and introns of the p53 gene in normal tissues and tumours.

MATERIALS AND METHODS: The prevalence of a polymorphism involving codon 72 of exon 4 in the p53 gene was studied in peripheral white blood cells and tumour tissues from Danish ovarian tumour patients and in peripheral white blood cells from controls. The analyses were performed by Polymerase Chain Reaction (PCR), Restriction Fragment Length Polymorphism (RFLP) and DNA sequencing. The amino acid residue at this position is either arginine (p53-Arg) or proline (p53-Pro).

RESULTS: There was no correlation between the frequency of the three genotypes (Pro/Pro, Arg/Arg and Arg/Pro) and age, stage or histological type of the tumour. A significant difference in survival was observed between ovarian cancer stage III patients with a shift from one genotype in the blood to another genotype in the tissue and patients with no shift (p=0.0216).

CONCLUSION: Kaplan-Meier survival analyses and multivariate Cox regression analysis stratified to stage III ovarian cancer patients showed that a shift from one genotype in the blood to another genotype in the tissue is a prognostic factor in Danish ovarian cancer patients.

OriginalsprogEngelsk
TidsskriftAnticancer Research
Vol/bind22
Udgave nummer3
Sider (fra-til)1859-64
Antal sider6
ISSN0250-7005
StatusUdgivet - 2002
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients'. Sammen danner de et unikt fingeraftryk.

Citationsformater